Your browser doesn't support javascript.
loading
Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea.
Kwon, Yunhyung; Hwang, Insob; Ko, Mijeong; Kim, Hyungjun; Kim, Seontae; Seo, Soon-Young; Cho, Enhi; Lee, Yeon-Kyeng.
Afiliación
  • Kwon Y; Adverse Event Information Analysis Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Hwang I; Adverse Event Information Analysis Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Ko M; Adverse Event Information Analysis Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim H; Adverse Event Management Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim S; Adverse Event Information Analysis Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Seo SY; Adverse Event Management Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Cho E; Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee YK; Adverse Event Management Team, Immunization Safety Group, COVID-19 Vaccination Task Force, Korea Disease Control and Prevention Agency, Cheongju, Korea.
Epidemiol Health ; 45: e2023006, 2023.
Article en En | MEDLINE | ID: mdl-37183320

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Epidemiol Health Año: 2023 Tipo del documento: Article Pais de publicación:

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Epidemiol Health Año: 2023 Tipo del documento: Article Pais de publicación: